Brind.

Eli Lilly announced multiple new partnerships, including expanding Zepbound access with CVS Health, collaborating with Insilico Medicine, and investing in an AI lab with NVIDIA.

1 report, 1 independent Updated Aug 28

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Eli Lilly and Company CVS Health Insilico Medicine

Keep exploring

The entities involved

Eli Lilly and Company
American pharmaceutical company
- Eli Lilly and Novo Nordisk are competing for market share in the weight loss drug sector.16:06
- AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.10:21
CVS Health
company
- Omnicom Group secured new mandates and account extensions from CVS Health, L'Oréal, Mercedes-Benz, and Novo Nordisk.Fri 12:38
- Morgan Stanley downgraded Range Resources, while analysts upgraded Duolingo, CVS Health, and Nextracker on August 18, 2025.Tue 10:22
Insilico Medicine
American biotechnology company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 28healthcare-digital.com